NCT05207904 2022-01-26Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain MetastasesSun Yat-sen UniversityPhase 2 Unknown41 enrolled
NCT00014105 2013-12-04Combination Chemotherapy in Treating Patients With Recurrent Glioblastoma MultiformeNational Cancer Institute (NCI)Phase 1/2 Unknown
NCT01342237 2013-11-19Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain TumorsSeoul National University HospitalPhase 2 Unknown33 enrolled
NCT00180791 2007-09-18High Risk Primitive Neuroectodermal (PNET) Brain Tumors in ChildhoodGustave Roussy, Cancer Campus, Grand ParisPhase 2 Unknown71 enrolled